Do alpha deletions influence hydroxyurea response in thalassemia intermedia?

Hematology

Volumn 10, Issue 1, 2005, Pages 61-63

  Panigrahi, I ^a   Dixit, A ^a   Arora, S ^a   Kabra, M ^a   Mahapatra, M ^a   Choudhry, V P ^a   Saxena, R ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Alpha deletions; Alpha genes; Beta thalassaemia; Globin gene mutation; HbF stimulation

Indexed keywords

ALPHA GLOBIN; BETA GLOBIN; HEMOGLOBIN; HEMOGLOBIN F; HYDROXYUREA;

ADOLESCENT; ADULT; ARTICLE; BETA THALASSEMIA; CHILD; CLINICAL ARTICLE; FEMALE; GENE; GENE DELETION; GENETIC POLYMORPHISM; GENOTYPE; GLOBIN GENE; HUMAN; MALE; PHENOTYPE; PRIORITY JOURNAL; TREATMENT OUTCOME; XMN I GENE;

ADOLESCENT; ADULT; BETA-THALASSEMIA; CHILD; CHILD, PRESCHOOL; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DRUG RESISTANCE; FEMALE; GENOTYPE; GLOBINS; HUMANS; HYDROXYUREA; MALE; POLYMORPHISM, GENETIC; PROGNOSIS; SEQUENCE DELETION; TREATMENT OUTCOME;

EID: 23244436397     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245330400020439     Document Type: Article

References (12)

1. Fucharoen S, Siritanaratkul N, Winichagoon P, Chowthaworn J, Siriboon W, Muangsup W, Chaicharoen S, Poolsup N, Chindavijak B, Pootrakul P, Piankijagum A, Schechter AN, Rodgers GP. Hydroxyurea increases hemoglobin levels and improves the effectiveness of erythropoeisis in beta- thalassaemia/hemoglobin E disease. Blood 1996;87(3):887-892.
2. Newton CR, Graham A, Heptinstall LE, Powell SJ, Summers C, Kalshekar N, Smith JC, Markham AF. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acid Res 1989;17:2503-2516.
3. Baysal E, Huisman TH. Detection of common deletional alpha-thalassaemia-2 determinants by PCR. Am J Hematol 1994;46(3):208-213.
4. Smetanina NS, Huisman TH. Detection of alpha-thalassaemia-2 (-3.7 kb) and its corresponding triplication (alpha)(alpha)(alpha) (anti-3.7kb) by PCR: an improved technical change. Am J Hematol 1996;53(3):202-203.
5. Chang JG, Lee LS, Lin CP, Chen PH. Rapid diagnosis of α-thalassemia-1 of South-east Asia type and hydrops fetalis by polymerase chain reaction. Blood 1991;78(3):853-854.
6. Leukopoulos D. New therapies for hemoglobinopathies. J Intern Med 1997;740(Suppl.):43-48.
7. Rigano P, Manfre L, la Galla R, Renda D, Renda MC, Calabrese A, Calzolari R, Maggio A. Clinical and hematological response to hydroxyurea in a patient with Hb Lepore/ beta-thalassaemia. Hemoglobin 1997;21(3):219-226.
8. Cario H, Wegener M, Debatin KM, Kohne E. Treatment with hydroxyurea in thalassemia intermedia with paravertebral pseudotumors of extramedullary hematopoiesis. Ann Hematol 2002;81(8):478-482.
9. de Paula EV, Lima CS, Arruda VR, Alberto FL, Saad ST, Costa FF. Long-term hydroxyurea therapy in beta thalassaemia patients. Eur J Haematol 2003;70(3):150-153.
10. Bradai M, Abad MT, Pissard S, Lamraoui F, Skopinski L, de Montalembert M. Hydroxyurea can eliminate transfusion requirements in children with severe beta-thalassaemia. Blood 2003;102(4):1529-1530.
11. Alebouyeh M, Moussavi F, Haddad-Deylami H, Vossough P. Hydroxyurea in the treatment of major beta-thalassemia and importance of genetic screening. Ann Hematol 2004;83(7):430-433.
12. Traeger-Synodinos J, Kanavakis E, Vrettou C, Maragoudaki E, Michael T, Metaxotou-Mavromati A, et al. The triplicated alpha-globin gene locus in beta-thalassaemia heterozygotes: clinical, haematological, biosynthetic and molecular studies. Br J Haematol 1996;95(3):467-471.